Dr. Alberto Ascherio of Harvard and Dr. Stephen Hauser of the University of California, San Francisco (UCSF) — will share $3 ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

A researcher at the University of California, San Francisco was honored for transforming the understanding and treatment of ...

Researchers had known that there was something odd about the development of MS, and attributed it to the so-called hygiene ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with ...

Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...

Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in ...

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

Feb. 27, 2025 — A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the ...

The findings reinforce the potential of BRIUMVI in improving patient outcomes for those seeking an alternative to their previous anti-CD20 therapy. Furthermore, the article in CNS DRUGS offers an ...

Feb. 27, 2025 — A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the ...